EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Wnt Signaling Pathway in Tumor Biology

Sabina Iluta, Madalina Nistor iD, Sanda Buruiana iD, Delia Dima

Genes · 2024

DOI: 10.3390/genes15121597 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2024. Verfasst von Sabina Iluta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400347 Cluj Napoca, Romania. Hauptthemen laut MEDLINE: Neoplasms, Wnt Signaling Pathway. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hatieganu University—School of Doctoral Studies, Romanian National Ministry of Research, Innovation and Digitalization, a collaborative grant between Romania and Moldova (2024–2025), Romanian Research Ministry—PNRR 2024–2026.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Relapse and metastasis are the major challenges that stand in the way of cancer healing and survival, mainly attributed to cancer stem cells (CSCs). Their capabilities of self-renewal and tumorigenic potential leads to treatment resistance development. CSCs function through signaling pathways such as the Wnt/β-catenin cascade. While commonly involved in embryogenesis and adult tissues homeostasis, the dysregulation of the Wnt pathway has direct correlations with tumorigenesis, metastasis, and drug resistance. The development of therapies that target CSCs and bulk tumors is both crucial and urgent. However, the extensive crosstalk present between Wnt and other signaling networks (Hedgehog and Notch) complicates the development of efficient long-term therapies with minimal side-effects on normal tissues. Despite the obstacles, the emergence of Wnt inhibitors and subsequent modulation of the signaling pathways would provide dynamic therapeutic approaches to impairing CSCs and reversing resistance mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsWnt Signaling PathwayAnimalsHumansCarcinogenesisDrug Resistance, NeoplasmNeoplastic Stem Cells

Stichwörter der Autor:innen

Wnt pathwaycancer stem cellstumor biology

Autor:innen und Institutionen

  • Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400347 Cluj Napoca, Romania.
  • Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400347 Cluj Napoca, Romania.
  • Department of Hematology, Nicolae Testemitanu University of Medicine and Pharmacy, 2004 Chisinau, Moldova.
  • Department of Hematology, Ion Chiricuta Oncology Institute, 400015 Cluj Napoca, Romania.

ORCID-Profile: Madalina Nistor, Sanda Buruiana

Förderung

  • Iuliu Hatieganu University—School of Doctoral Studies
  • Romanian National Ministry of Research, Innovation and Digitalization, a collaborative grant between Romania and Moldova (2024–2025)
  • Romanian Research Ministry—PNRR 2024–2026

Zitieren

APA

Iluta, S., Nistor, M., Buruiana, S., & Dima, D. (2024). Wnt Signaling Pathway in Tumor Biology. Genes. https://doi.org/10.3390/genes15121597

Vancouver

Iluta S, Nistor M, Buruiana S, Dima D. Wnt Signaling Pathway in Tumor Biology. Genes. 2024. doi:10.3390/genes15121597

BibTeX
@article{Iluta2024,
  author = {Iluta, Sabina and Nistor, Madalina and Buruiana, Sanda and Dima, Delia},
  title = {Wnt Signaling Pathway in Tumor Biology},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15121597}
}
Kostenlos starten →